Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cure.
Leeor HershkovichLouis M ShekhtmanMichel BazinetVictor PânteaGheorge PlacintaScott J CotlerAndrew VaillantHarel DahariPublished in: Hepatology communications (2023)
Functional cure was associated with a rapid monophasic HBsAg decline during NAP-based therapy. A nonmonophasic HBsAg kinetic pattern had a 100% negative predictive value (NPV) for a functional cure.